Literature DB >> 4541673

Impaired lymphocyte transformation in Hodgkin's disease. Evidence for depletion of circulating t-lymphocytes.

K M Matchett, A T Huang, W B Kremer.   

Abstract

The kinetics of lymphocyte transformation induced by phytohemagglutinin (PHA) and pokeweed mitogen (PWM) were studied daily, with blood lymphocytes from normal individuals and from untreated patients in all stages of Hodgkin's disease (HD). In addition, spleen lymphocytes and lymph node lymphocytes were studied with similar techniques.Peripheral blood lymphocyte transformation stimulated by PHA was found to be depressed in all patients with HD (including those with localized disease and no symptoms) when small numbers of lymphocytes were cultured and studied during a 7-day period. Most patients with HD had an increased number of cells circulating in their blood which were actively synthesizing DNA. HD lymphocytes which demonstrated the highest initial rate of spontaneous DNA synthesis usually did not respond to PHA stimulation. Blood lymphocytes from normal individuals responded equally well to PHA and PWM in our system. HD blood lymphocytes consistently responded better to PWM than to PHA, with the response to PWM frequently within the normal range. Unless the spleen was extensively infiltrated with HD, spleen lymphocytes from patients with HD responded to PHA, even though the blood lymphocyte response was severely reduced. Lymph node lymphocyte response to PHA from patients with HD was variable, but correlated roughly with the blood lymphocyte response. It is hypothesized from the data presented that in HD, circulating thymus-dependent (T-)lymphocytes are stimulated by the presence of active disease. This stimulation of T-lymphocytes leads to a circulating T-cell depletion and to an increase in the number of cells circulating that are active in DNA synthesis. The degree of impairment of cell-mediated immunity would then depend upon the degree of T-lymphocyte depletion.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4541673      PMCID: PMC302472          DOI: 10.1172/JCI107374

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  45 in total

1.  A system for lymphocytes in the mouse.

Authors:  A J Davies; E Leuchars; V Wallis; M J Doenhoff
Journal:  Proc R Soc Lond B Biol Sci       Date:  1971-01-12

2.  The thymus and circulating lymphocytes of mice.

Authors:  M J Doenhoff; A J Davies; E Leuchars; V Wallis
Journal:  Proc R Soc Lond B Biol Sci       Date:  1970-10-13

3.  Pathogenesis of Hodgkin's disease.

Authors:  S E Order; S Hellman
Journal:  Lancet       Date:  1972-03-11       Impact factor: 79.321

4.  Hodgkin's disease: evidence for a tumor-associated antigen.

Authors:  S E Order; M Porter; S Hellman
Journal:  N Engl J Med       Date:  1971-08-26       Impact factor: 91.245

5.  In vitro studies of the human response to organ allografts: appearance and detection of circulating activation lymphocytes.

Authors:  E M Hersh; W T Butler; R D Rossen; R O Morgan; W Suki
Journal:  J Immunol       Date:  1971-08       Impact factor: 5.422

6.  In vitro reactivity of human lymphocytes in chronic uraemia: analysis and interpretation.

Authors:  J C Daniels; H Sakai; A R Remmers; H E Sarles; J C Fish; E K Cobb; W C Levin; S E Ritzmann
Journal:  Clin Exp Immunol       Date:  1971-02       Impact factor: 4.330

7.  Delayed hypersensitivity in Hodgkin's disease. A study of 103 untreated patients.

Authors:  R C Young; M P Corder; H A Haynes; V T DeVita
Journal:  Am J Med       Date:  1972-01       Impact factor: 4.965

8.  Lymphocyte reactivity in vitro. VII. The effect of polymorphonuclear leukocytes on lymphocyte response.

Authors:  M L Bach; F H Bach; M Widmer; H Oranen; W H Wolberg
Journal:  Transplantation       Date:  1971-10       Impact factor: 4.939

9.  Lymphocyte activation. I. Response of T and B lymphocytes to phytomitogens.

Authors:  G Janossy; M F Greaves
Journal:  Clin Exp Immunol       Date:  1971-10       Impact factor: 4.330

10.  Bone marrow: the bursa equivalent in man?

Authors:  N I Abdou; N L Abdou
Journal:  Science       Date:  1972-01-28       Impact factor: 47.728

View more
  14 in total

1.  B and T lymphocytes in Hodgkin's disease. Analysis at diagnosis and following therapy.

Authors:  K J Gajl-Peczalska; C D Bloomfield; H Sosin; J H Kersey
Journal:  Clin Exp Immunol       Date:  1976-01       Impact factor: 4.330

2.  Immune function of successfully treated lymphoma patients.

Authors:  G W King; B Yanes; P E Hurtubise; S P Balcerzak; A F LoBuglio
Journal:  J Clin Invest       Date:  1976-06       Impact factor: 14.808

3.  Suggested models of ecotaxopathy in lymphoreticular malignancy. A role for iron-binding proteins in the control of lymphoid cell migration.

Authors:  M de Sousa; A Smithyman; C Tan
Journal:  Am J Pathol       Date:  1978-02       Impact factor: 4.307

4.  Cell-mediated cytotoxic activity of spleen cells from patients with gastric carcinoma.

Authors:  T Akiyoshi; F Koba; S Arinaga; T Wada; H Tsuji
Journal:  Jpn J Surg       Date:  1988-03

5.  Immunorestorative properties of thymostimulin (TS) in patients with Hodgkin's disease in clinical remission.

Authors:  A M Liberati; M Brugia; B S Edwards; P Bertoni; E Ballatori; A Puxeddu; F Grignani
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

6.  Ecotaxis: the principle and its application to the study of Hodgkin's disease.

Authors:  M D Sousa; M Yang; E Lopes-Corrales; C Tan; J A Hansen; B Dupont; R A Good
Journal:  Clin Exp Immunol       Date:  1977-01       Impact factor: 4.330

7.  The T and B lymphocyte content of lymph nodes and spleen in Hodgkin's disease.

Authors:  G Stathopoulos; M Papamichail; M J Peckham; A J Davies; E J Holborow
Journal:  Br J Exp Pathol       Date:  1977-12

8.  Kinetic studies of circulating lymphocytes in malignant lymphatic disease using the impulse cytophotometer.

Authors:  F J Cleton; L A Smets; H Van Rooy; A M Boogaards
Journal:  Br J Cancer Suppl       Date:  1975-03

9.  Abnormalities of in vitro immunoglobulin synthesis by peripheral blood lymphocytes from untreated patients with Hodgkin's disease.

Authors:  S Romagnani; G F Del Prete; E Maggi; G Bellesi; G Biti; P L Rossi Ferrini; M Ricci
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

10.  Reduced monocyte phagocytosis in patients with advanced Hodgkin's disease and lymphosarcoma.

Authors:  D Urbanitz; I Fechner; R Gross
Journal:  Klin Wochenschr       Date:  1975-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.